"Key opinion leaders were salespeople for us, and we would routinely measure the return on our investment, by tracking prescriptions before and after their presentations," she said. "If that speaker didn’t make the impact the company was looking for, then you wouldn’t invite them back."It is another nail in the coffin of the notion that drug companies pay doctors to provide medical education. It's all about marketing.
Tuesday, June 24, 2008
Key Opinion Leaders as Drug Reps
I just noticed this interesting post over on Health Care Renewal reviewing this article in the British Medical Journal. The article interviews a former U.S. drug rep, Kimberly Eliot, who recounts how key opinion leaders are groomed to be salespeople for the pharmaceutical industry: